SCHEMBL6046403

SCHEMBL6046403

Cc1ccc(S(=O)(=O)C(O)C(O)CO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
ALDH1A1 P00352 6/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA12 O43570 1/20 0.41
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
KMT2A Q03164 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925591 1.00 GAA (0.43) GAAALDH1A1CA1CA2MMP1
SCHEMBL4927264 1.00 GAA (0.43) GAAALDH1A1CA1CA2MMP1
SCHEMBL29771132 0.86 TDP1 (0.39) GAAALDH1A1CA1CA2MMP1
SCHEMBL30121315 0.84 GAA (0.54) GAAALDH1A1CA1CA2MMP1
SCHEMBL11198034 0.84 GAA (0.42) GAAALDH1A1CA1CA2MMP1
SCHEMBL28292240 0.81 GAA (0.46) GAAALDH1A1CA1CA2MMP1
SCHEMBL8959293 0.80 GAA (0.50) GAAALDH1A1CA1CA2MMP1
E968 SCHEMBL2057570 0.79 ALDH1A1 (0.47) GAAALDH1A1CA1CA2MMP1
SCHEMBL669227 0.79 GAA (0.48) GAAALDH1A1CA1CA2MMP1
SCHEMBL25678915 0.79 GAA (0.48) GAAALDH1A1CA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462735-A Lysophosphatidyl Process for the preparation of choline 苏州昊帆生物股份有限公司 2025-02-18 CN disclosed
EP-1578723-A4 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF UNIV MICHIGAN STATE (US) 2006-11-02 EP disclosed
EP-1578723-A3 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2005-10-20 EP disclosed
EP-1578723-A2 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2005-09-28 EP disclosed
WO-2003106413-A2 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2003-12-24 WO disclosed
EP-0094586-A2 Glycerol derivatives, process for preparing same and pharmaceutical composition containing same ONO PHARMACEUTICAL CO., LTD. (JP) 1983-11-23 EP disclosed
EP-0013856-B1 NEW COMPOUNDS ASSOCIATING PEPTIDYL OR AMINOACYL RESIDUES TO LIPOPHILIC GROUPS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID NEW COMPOUNDS ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1983-03-09 EP disclosed
US-4335111-A BACTERICIDES AGENCE NATIONAL DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1982-06-15 US disclosed
EP-0013856-A1 New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1980-08-06 EP disclosed